Latest Paliperidone Stories

2013-11-05 23:26:47

The Agreement Settles Charges that Johnson & Johnson Illegally Marketed Risperdal, Invega and Natracor for Off-Label Use and Paid Kick-Backs to Physicians to Drive Sales of Risperdal and Invega, Alonso Krangle LLP reports. New York, NY (PRWEB) November 05, 2013 Johnson & Johnson has agreed to pay $2.2 billion to settle charges with the U.S. Department of Justice (DOJ) over the alleged illegal marketing of Risperdal, Invega and Natrecor, Alonso Krangle LLP reports. In a press...

2012-03-21 13:55:32

Physicians who prescribe antipsychotic medications may be basing their decisions on incomplete information, according to new research published by scientists at Oregon Health & Science University. The study is published in PLoS Medicine, a peer-reviewed open-access journal published by the Public Library of Science. This latest research follows a highly publicized 2008 report in the New England Journal of Medicine demonstrating that antidepressant drug trials were selectively...

2012-03-21 10:23:03

A study in this week's PLoS Medicine suggests that the apparent clinical effectiveness of the newer form of drugs used to treat schizophrenia and other psychotic illnesses (second-generation anti-psychotic drugs) may be enhanced by the selective reporting of trials of these drugs in medical journals — a phenomenon called publication bias. This finding is important as the results of published trials influence clinicians' decisions to prescribe drugs. The authors, led by Erick Turner...

2012-03-21 05:45:59

(Ivanhoe Newswire) — If you´re in pain, there´s a pill for that! But it may not always be good. A new study shows clinical effectiveness of the newer form of drugs used to treat schizophrenia and other psychotic illnesses may be enhanced by a phenomenon called publication bias. The study, led by Erick Turner from Oregon Health & Science University in Portland, shows selective reporting of research results undermines the integrity of the evidence base, which ultimately...

2011-09-27 18:09:48

A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these medications are effective for only a few off-label conditions, and that the benefits and harms of these medications for these uses vary, according to an article in the September 28 issue of JAMA. "Atypical antipsychotic medications are approved for marketing and...

Word of the Day
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'